In our study, the levels of IL-1β, Fas, or BDNF did not differ between patients suffering from schizophrenia and healthy controls; however, significant correlations were found between the studied markers and clinical symptom severity, disease duration, the type of treatment. Here, FAS is linked to schizophrenia.